Tiziana Life Sciences (TILS)

 

TILS Share PerformanceMore

52 week high224.80 17/11/16
52 week low91.35 27/04/16
52 week change 68.00 (53.97%)
4 week volume68,539 28/02/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Tiziana Life Sciences notes exercise of warrants

Tiziana Life Sciences has received a notification from warrant holders to exercise warrants over 1.8m shares at an exercise...

Exercise of Warrants & Issue of Equity

RNS Number: 3990A Tiziana Life Sciences PLC 24 March 2017 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Exercise of Warrants & Issue of Equity London, 24 March 2017 - Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces ...

Arun Sanyal appointed to Scientific Advisory Board

RNS Number: 3208Z Tiziana Life Sciences PLC 14 March 2017 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board Dr. Arun Sanyal is a distinguished professor and a key opinion leader in liver diseases such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepati...

Warrant Expiry - Reminder

RNS Number: 1951U Tiziana Life Sciences PLC 16 January 2017 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Warrant Expiry - Reminder London, 16 January 2017 - The Directors of Tiziana Life Sciences plc (AIM: TILS) ("Tiziana" or "the Company") hereby provide an update in respect of the series "B" warrants issued to investors on 18 June 2014 ("Warr...

Tiziana Life Sciences in-licences NI-1201

Tiziana Life Sciences has announced the acquisition of an exclusive world-wide license for NI-1201, a fully human anti-inte...

Tiziana Life Sciences in-licenses NI-1201

RNS Number: 1265T Tiziana Life Sciences PLC 03 January 2017 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Tiziana Life Sciences in-licenses NI-1201, a fully human anti-IL-6R monoclonal antibody Exclusive world-wide license expands therapeutic pipeline in key immunological areas London, 3 January 2017 - Tiziana Life Sciences plc (AIM: TILS, the "Co...

Tiziana announces new data with Foralumab

Tiziana Life Sciences announces new data from animal studies demonstrating the potential of its novel oral therapy with f...

New Data with Foralumab

RNS Number: 2686P Tiziana Life Sciences PLC 16 November 2016 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Tiziana Life Sciences Announces New Data with Foralumab, a Fully Human Anti-CD3 Antibody Being Developed as an Oral Therapy for NASH and Autoimmune Diseases London, 16 November 2016 - Tiziana Life Sciences plc (AIM: TILS, the...

Fundamental DataMore

EPS-9.5
Dividend yield0 %

Equity Research (TILS)

equity development
Tiziana Life Sciences PLC
26/01/2015
TILS has just announced an exclusive license with Nerviano Medical Sciences (NMS) for its Phase 2 anti-cancer drug candidate, milciclib. It helps block the rampant cell division associated with...
equity development
Tiziana Life Sciences PLC
12/01/2015
Tiziana (TILS) and Novimmune S.A., a company focused on the discovery and development of antibody-based drugs to benefit patients with inflammatory, auto-immune disorders, and cancer, have announced...
equity development
Tiziana Life Sciences PLC
30/09/2014
Tiziana Life Sciences (TILS) has identified a potential 'master regulator' for metastatic breast cancer (mBC). 'Bcl-3 inhibition' would be a novel strategy for treatment,...

Latest discussion posts More

  • Fundraise

    Beaufort Securities's note out this morning on Research Tree: "Tiziana progressed well during the FY2015. It strengthened its portfolio by acquiring exclusive licence for both ...
    8-Jun-2016
    Simbr
  • no buying

    With sp @110 and bid @ 115 I tried buying 2500 online at Barclays. Quoted 187.4 Obviously buying is being discouraged for whatever reason
    28-Apr-2016
    osammyboy
  • More cheap shares for the boys. When can we get some?
    15-Jan-2016
    osammyboy

Users' HoldingsMore

Users who hold Tiziana Life Sciences also hold..
ID:ISIN:GB00B474YB1265%
LLOYDS GRP.27%
ROYAL BANK SCOT23%
TAYLOR WIMPEY13%
MIRADA13%

Codes & Symbols

ISINGB00BKWNZY55
SymbolsTILS, LSE:TILS, TILS.L, TILS:LN, LON:TILS, XLON:TILS